Published in Oncotarget on September 27, 2016
Cancer cell cycles. Science (1996) 21.29
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell (2012) 6.49
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity (2011) 6.00
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell (2006) 4.98
The biology of Hodgkin's lymphoma. Nat Rev Cancer (2008) 3.31
Critical roles for transcription factor GATA-3 in thymocyte development. Immunity (2003) 3.15
CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev (1998) 2.91
GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol (2009) 2.43
Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J (2000) 2.21
CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell (2009) 2.17
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation. Genes Dev (2005) 2.14
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood (2006) 2.10
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet (2010) 1.78
Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood (2010) 1.69
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood (2014) 1.66
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life (2007) 1.63
Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest (2003) 1.63
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene (2005) 1.61
Haploinsufficiency of p18(INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol (2003) 1.58
Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene (2012) 1.52
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet (2013) 1.45
Human innate lymphoid cells. Blood (2014) 1.42
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood (2014) 1.32
GATA-3 regulates the self-renewal of long-term hematopoietic stem cells. Nat Immunol (2013) 1.19
GATA-3 function in innate and adaptive immunity. Immunity (2014) 1.16
GATA-3 regulates hematopoietic stem cell maintenance and cell-cycle entry. Blood (2012) 1.14
Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J Immunol (2001) 1.13
p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control. Mol Cell Biol (2006) 1.11
p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Res (2007) 1.10
An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol (2001) 1.09
GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood (2013) 1.08
GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling. Nat Immunol (2013) 1.06
GATA3 is redundant for maintenance and self-renewal of hematopoietic stem cells. Blood (2011) 1.05
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood (2014) 1.04
Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas. Blood (2003) 1.03
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood (2013) 1.02
GATA3: a master of many trades in immune regulation. Trends Immunol (2014) 0.96
Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood (2010) 0.94
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol (2005) 0.94
GATA-3 dose-dependent checkpoints in early T cell commitment. J Immunol (2014) 0.89
What can we learn from leukemia as for the process of lineage commitment in hematopoiesis? Int Rev Immunol (2001) 0.89
Transcriptional repression of Gata3 is essential for early B cell commitment. Immunity (2013) 0.89
Gata3/Ruvbl2 complex regulates T helper 2 cell proliferation via repression of Cdkn2c expression. Proc Natl Acad Sci U S A (2013) 0.86
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res (2014) 0.85
A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros. Leukemia (2015) 0.81
Lack of MSH2 involvement differentiates V(D)J recombination from other non-homologous end joining events. Nucleic Acids Res (2005) 0.78
A monoallelic-to-biallelic T-cell transcriptional switch regulates GATA3 abundance. Genes Dev (2015) 0.76